#Sclerodermas

世界中の人々によるSclerodermasに関する件のリール動画を視聴。

ログインせずに匿名で視聴。

トレンドリール

(4)
#Sclerodermas Reel by @sclerodermajourney_chelby - Thanking my family for participating in Rare Disease Day yesterday. This was lovely to see @rarediseasedayofficial #showyourstripes #sclerodermaawaren
151
SC
@sclerodermajourney_chelby
Thanking my family for participating in Rare Disease Day yesterday. This was lovely to see @rarediseasedayofficial #showyourstripes #sclerodermaawareness #sclerodermawarrior #helpfindacureforscleroderma
#Sclerodermas Reel by @themoexperience25 - #RareDiseaseDay #raredc2026 #themoexperience25 #RareButNotInvisible #sclerodermaawareness #EquityForRare
140
TH
@themoexperience25
#RareDiseaseDay #raredc2026 #themoexperience25 #RareButNotInvisible #sclerodermaawareness #EquityForRare
#Sclerodermas Reel by @road_back_foundation (verified account) - Is scleroderma a treatable infection?
The data from the Road Back Foundation patient community says this question must be asked.
In a review of 304 in
150
RO
@road_back_foundation
Is scleroderma a treatable infection? The data from the Road Back Foundation patient community says this question must be asked. In a review of 304 individuals diagnosed with systemic scleroderma who shared their outcomes on the RBF Patient Community Discussion Forum: • 221 patients (73%) reported remission • 82 patients (27%) reported noticeable improvement • Only 2 patients (<1%) reported no improvement Even more striking — among 97 scleroderma patients who reported being tested for Lyme disease: • 71 (73%) tested positive • 24 (25%) tested negative • Lyme testing is known to produce high false-negative rates These outcomes were reported by patients using antibiotic protocol therapy, a treatment approach first advanced by rheumatologist Dr. Thomas McPherson Brown and supported by decades of clinical experience. Yet today, most scleroderma patients are still placed on long-term immune-suppressing drugs — often without being screened for infectious triggers that may be driving the disease process. Before suppressing the immune system, shouldn’t we rule out infection? At Road Back Foundation, we believe: ✔️ Scleroderma should be evaluated as a potentially infection-driven illness ✔️ Patients deserve comprehensive screening before irreversible treatment decisions ✔️ First, do no harm must remain the guiding principle of care 📌 These data reflect real-world patient-reported outcomes from one of the largest scleroderma-focused communities in the world. 🔗 Learn more at RoadBack.org #Scleroderma #SystemicSclerosis #LymeDisease #LymeArthritis #InfectiousAutoimmunity #AntibioticProtocol #APTherapy #AutoimmuneDisease #RareDisease #PatientReportedOutcomes #MedicalFreedom #InformedConsent #ChronicIllness #Misdiagnosis #FunctionalMedicine #IntegrativeMedicine #RoadBackFoundation #FirstDoNoHarm
#Sclerodermas Reel by @sclerodermacan - Today on Rare Disease Day, we're talking about something that doesn't always get the spotlight - policy.
Policy might sound technical or political. Bu
728
SC
@sclerodermacan
Today on Rare Disease Day, we’re talking about something that doesn’t always get the spotlight — policy. Policy might sound technical or political. But for people living with rare diseases, policy is personal. It determines: • How long it takes to get diagnosed • Whether treatments are covered • If life-saving medications are affordable • How quickly new therapies are approved • Whether patients can access specialists close to home • How research is funded For rare diseases like systemic sclerosis, delays and gaps in the system don’t just create inconvenience — they compound disease burden. Diagnostic delays, limited drug access, and inconsistent coverage across provinces are not medical problems alone. They are policy problems. Good policy means: ✔ Faster diagnoses ✔ Fair and equitable drug access ✔ Investment in research ✔ Support for caregivers ✔ A stronger, more responsive health system On Rare Disease Day, we honour the strength of our community — and we reaffirm that advocacy matters. Because when policy improves, lives improve. #RareDiseaseDay #PolicyMatters #HealthEquity #RareDiseaseAdvocacy

✨ #Sclerodermas発見ガイド

Instagramには#Sclerodermasの下にthousands of件の投稿があり、プラットフォームで最も活気のあるビジュアルエコシステムの1つを作り出しています。

ログインせずに最新の#Sclerodermasコンテンツを発見しましょう。このタグの下で最も印象的なリール、特に@sclerodermacan, @sclerodermajourney_chelby and @road_back_foundationからのものは、大きな注目を集めています。

#Sclerodermasで何がトレンドですか?最も視聴されたReels動画とバイラルコンテンツが上部に掲載されています。

人気カテゴリー

📹 ビデオトレンド: 最新のReelsとバイラル動画を発見

📈 ハッシュタグ戦略: コンテンツのトレンドハッシュタグオプションを探索

🌟 注目のクリエイター: @sclerodermacan, @sclerodermajourney_chelby, @road_back_foundationなどがコミュニティをリード

#Sclerodermasについてのよくある質問

Pictameを使用すれば、Instagramにログインせずに#Sclerodermasのすべてのリールと動画を閲覧できます。あなたの視聴活動は完全にプライベートです。ハッシュタグを検索して、トレンドコンテンツをすぐに探索開始できます。

パフォーマンス分析

4リールの分析

🔥 高競争

💡 トップ投稿は平均439.5回の再生(平均の1.5倍)

ピーク時間(11-13時、19-21時)とトレンド形式に注目

コンテンツ作成のヒントと戦略

🔥 #Sclerodermasは着実な成長を示す - 一貫して投稿してプレゼンスを構築

✍️ ストーリー性のある詳細なキャプションが効果的 - 平均長809文字

✨ 多くの認証済みクリエイターが活動中(25%) - コンテンツスタイルを研究

📹 #Sclerodermasには高品質な縦型動画(9:16)が最適 - 良い照明とクリアな音声を使用

#Sclerodermas に関連する人気検索

🎬動画愛好家向け

Sclerodermas ReelsSclerodermas動画を見る

📈戦略探求者向け

Sclerodermasトレンドハッシュタグ最高のSclerodermasハッシュタグ

🌟もっと探索

Sclerodermasを探索#linear scleroderma awareness month#morphea scleroderma#scleroderma and autoimmune diseases#scleroderma awareness month#scleroderma treatment options 2026#localized scleroderma#scleroderma support groups online#scleroderma symptoms in women